Marco Lotti
From 1995 to 1999 he was member of the Scientific Committee for trials on colorectal cancer screening of the European Institute of Oncology.
He was teacher and tutor in several Master Courses on Mini-invasive Surgery at the Aesculapium of Tuttlingen (Germany) and the IRCAD (Research Institute Against Digestive Cancer) of Strasbourg (France).
He is author of several teaching videos on Laparoscopic Surgical Technique (Aesculap Academy – Tuttlingen), (MedTutor Surgery – UTET), (Surg Endosc. 2016 Apr 8. doi 10.1007/s00464-016-4884-z), (WeBSurg.com, Feb 2016;16(02). URL: http://www.websurg.com/doi-vd01en4678.htm).
He is member of the Gastro-Intestinal Oncology Group (GIOG) and Rare Tumors Group (GNR) at Papa Giovanni XXIII Hospital – Bergamo.
He is investigator and proposer of the CHORINE Study – multicentre clinical trial on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for upfront treatment of advanced epithelial ovarian cancer.
He is the creator and proposer of the Laparoscopy-enhanced HIPEC technique (J Min Access Surg 2016;12:86-9), (JLAST Part B, Videoscopy 2016; doi: 10.1089/vor.2015.0315) and of an original technique of laparoscopic right colectomy (J Min Access Surg 2016;12:41-6).
He is Reviewer for Surgical Endoscopy, the Journal of Laparoendoscopic & Advanced Surgical Techniques Part B, Videoscopy and Oncotarget.
He is committed to surgical treatment of gastrointestinal cancer, peritoneal surface malignancies and tumors of the adrenals, the paraganglia and the retroperitoneum.
He was teacher and tutor in several Master Courses on Mini-invasive Surgery at the Aesculapium of Tuttlingen (Germany) and the IRCAD (Research Institute Against Digestive Cancer) of Strasbourg (France).
He is author of several teaching videos on Laparoscopic Surgical Technique (Aesculap Academy – Tuttlingen), (MedTutor Surgery – UTET), (Surg Endosc. 2016 Apr 8. doi 10.1007/s00464-016-4884-z), (WeBSurg.com, Feb 2016;16(02). URL: http://www.websurg.com/doi-vd01en4678.htm).
He is member of the Gastro-Intestinal Oncology Group (GIOG) and Rare Tumors Group (GNR) at Papa Giovanni XXIII Hospital – Bergamo.
He is investigator and proposer of the CHORINE Study – multicentre clinical trial on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for upfront treatment of advanced epithelial ovarian cancer.
He is the creator and proposer of the Laparoscopy-enhanced HIPEC technique (J Min Access Surg 2016;12:86-9), (JLAST Part B, Videoscopy 2016; doi: 10.1089/vor.2015.0315) and of an original technique of laparoscopic right colectomy (J Min Access Surg 2016;12:41-6).
He is Reviewer for Surgical Endoscopy, the Journal of Laparoendoscopic & Advanced Surgical Techniques Part B, Videoscopy and Oncotarget.
He is committed to surgical treatment of gastrointestinal cancer, peritoneal surface malignancies and tumors of the adrenals, the paraganglia and the retroperitoneum.
less
Uploads
Papers by Marco Lotti
FULL VIDEO AT:
https://youtu.be/4L8ANPCqosM
I decided to write these notes to fix those thoughts and use them to help me and anyone who is interested to investigate the different aspects of my idea.
I want to clarify that many of the considerations that you will find here are just my assumptions that need to be confirmed by properly designed studies.
I hope these notes will help to further understand the principles and aims of the LE-HIPEC technique.